findmyKOL

Marco Caccamo, DO

Basic profile

West Virginia University

ORCIDNPI
RegionMorgantown, WV · SoutheastSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Marco Caccamo is a Cardiology physician affiliated with West Virginia University. OpenAlex indexes 87 publications with 513 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
87publications

Distinct works indexed by OpenAlex, matched via ORCID.

513citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1 Medical Center Dr
Morgantown, WV 265061200

Telephone

304-598-4800

Provider last certified this registry record 8 Apr 2022.

View the NPPES registry record

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    68.3%
    Aldosterone antagonist (MRA)10.5%
    Spironolactone89%Eplerenone11%
    Part D<11 patients
    Loop diuretic9.8%
    Furosemide69%Torsemide31%
    Part D34 patients

    + 11 more classes in this area

  • Metabolism & gastrointestinal

    14.4%
    SGLT2 inhibitor8%
    Jardiance76%Farxiga24%
    Part D24 patients
    Potassium supplement4.7%
    Potassium Chloride75%Klor-Con M2025%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    10.4%
    Factor Xa inhibitor3.6%
    Eliquis100%
    Part D<11 patients
    Vitamin K antagonist3.1%
    Warfarin Sodium100%
    Part D12 patients

    + 3 more classes in this area

Where care is delivered (Part B)89% facility · 11% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”